Publication: Antidepressant drug use in glioblastoma patients: an epidemiological view.
Antidepressant drug use in glioblastoma patients: an epidemiological view.
Date
Date
Date
Citations
Gramatzki, D., Rogers, J. L., Neidert, M. C., Hertler, C., Le Rhun, E., Roth, P., & Weller, M. (2020). Antidepressant drug use in glioblastoma patients: an epidemiological view. Neuro-Oncology Practice, 7(5), 514–521. https://doi.org/10.1093/nop/npaa022
Abstract
Abstract
Abstract
Background: Antidepressant drugs have shown antitumor activity in preclinical glioblastoma studies. Antidepressant drug use, as well as its association with survival, in glioblastoma patients has not been well characterized on a population level. Methods: Patient characteristics, including the frequency of antidepressant drug use, were assessed in a glioblastoma cohort diagnosed in a 10-year time frame between 2005 and 2014 in the Canton of Zurich, Switzerland. Cox proportional hazards regression models were applied for multivariate a
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
Additional Information
Additional Information
Additional Information
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Gramatzki, D., Rogers, J. L., Neidert, M. C., Hertler, C., Le Rhun, E., Roth, P., & Weller, M. (2020). Antidepressant drug use in glioblastoma patients: an epidemiological view. Neuro-Oncology Practice, 7(5), 514–521. https://doi.org/10.1093/nop/npaa022